Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Catherine Deguines"'
Autor:
Wladimir Kawiecki, Alexis Genin, Alexandra Auffret, Olivier Blin, Sarah Catoen, Catherine Deguines, Nabil Bédira, Jean-Robert Deverre, Jean-Marie Goehrs, Joëlle Micallef, Bertrand Loubaton, Jean-François Mangin, Pierre Payoux, Cyril Poupon, Jean-Philippe Ranjeva, Guy Turquet de Beauregard, Nicolas Villain, Nadine Weisslinger, Mohammed Zaim
Publikováno v:
Therapies. 67:295-300
Resume L’objectif de la table ronde etait d’aborder la place de la neuroimagerie clinique et preclinique dans le developpement de nouveaux medicaments dans les pathologies neurodegeneratives pour la premiere fois lors des rencontres de Giens. Les
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa415d3adf12a0dc85ac6db9fa28c763
https://doi.org/10.2515/therapie/2012047
https://doi.org/10.2515/therapie/2012047
Autor:
Régis Bordet, Jean-François Dartigues, Bruno Dubois, Jean-Marie Goehrs, Laura Vernoux, Franck Semah, Florence Pasquier, Claude Bidaut-Mazel, Zeina Antoun, Olivier Arnaud, Olivier Blin, Catherine Deguines, Philippe Derambure, Patrice Dosquet, Jean Pierre Duffet, Sylvia Goni, Philippe Gustovic, Marie Lang, Marie-Laure Laroche, Antoine Pariente, Jean-Jacques Pere, Odile Regnier, Philippe Truffinet
Publikováno v:
Therapies. 65:277-283
Resume Le developpement clinique de medicaments disease-modifiers dans la maladie d’Alzheimer se heurte a des difficultes methodologiques dont temoignent plusieurs echecs recents de medicaments en phase III. Compte-tenu des enjeux financiers inhere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0143dd98c706bb29a21547b4c6c0f99b
https://doi.org/10.2515/therapie/2010039
https://doi.org/10.2515/therapie/2010039
Autor:
Thierry Marquet, Catherine Deguines, Yves Juillet, B. Boneu, S. Bonin-Guillaume, S. Bonnot-Marlier, C.-A. Cudennec, R. Bordet, J. Doucet, L. Feldmann, S. Goni, M. Jeantet, V. Lamarque, H. Lelouet, S. Legrain, P. Maillière, L. Merle, M.-F. Padioleau, S. Personnic, F. Piette, P. Prévost, O. Réveillaud, J.-R. Royer, J. Soletti, J.-L. Vetel
Publikováno v:
Therapies. 60:373-377
Over the last few years, there has been a rapid and steadily expanding demographic explosion in the elderly population in France. When the most dynamic segment of this growth is considered, i.e. patients aged 80 years or more (who, moreover, usually
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f55a54b313db633ab3a3232944292c16
https://doi.org/10.2515/therapie:2005054
https://doi.org/10.2515/therapie:2005054
Autor:
J.-L. Vetel, S. Bonnot-Marlier, P. Prévost, Thierry Marquet, F. Piette, Jean Doucet, O. Réveillaud, P. Maillière, J. Soletti, H. Lelouet, L. Feldmann, B. Boneu, Yves Juillet, M. Jeantet, S. Goni, L. Merle, S. Legrain, S. Personnic, Sylvie Bonin-Guillaume, C.-A. Cudennec, Catherine Deguines, M.-F. Padioleau, R. Bordet, V. Lamarque, J.-R. Royer
Publikováno v:
Therapies. 60:367-371
Resume L’explosion demographique des sujets âges en France est en pleine et durable expansion depuis quelques annees. Si on s’interesse au segment le plus dynamique de cette croissance, a savoir plus particulierement les patients âges de 80 ans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63bd9dd9f00b8349b9563a30ddd813cd
https://doi.org/10.2515/therapie:2005053
https://doi.org/10.2515/therapie:2005053
Autor:
Florian Strasser, Mark P. Jensen, Stein Kaasa, Tarja Heiskanen, John T. Farrar, Oscar Corli, Nan E. Rothrock, Catherine Deguines, G. Apolone, Pål Klepstad, Massimo Costantini, Mogens Groenvold, Marianne Jensen Hjermstad, Robin L. Fainsinger, J. H. Loge, James Cleary, Vittorina Zagonel, Henry J. McQuay, Augusto Caraceni
Publikováno v:
BMJ supportivepalliative care. 1(3)
An increasing number of cancer patients live longer, and palliative care has become an important part of their treatment. Symptoms are often inadequately assessed and managed. A significant challenge in clinical trials is to control for the variabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2623dd0f23f3117183a5f457c8718f
https://pubmed.ncbi.nlm.nih.gov/24653469
https://pubmed.ncbi.nlm.nih.gov/24653469
Autor:
Régis Bordet, Jean-François Dartigues, Bruno Dubois, Jean-Marie Goehrs, Laura Vernoux, Franck Semah, Florence Pasquier, Claude Bidaut-Mazel, Zeina Antoun, Olivier Arnaud, Olivier Blin, Antoine Coquerel, Catherine Deguines, Philippe Derambure, Patrice Dosquet, Jean-Pierre Duffet, Sylvia Goni, Philippe Gustovic, Marie Lang, Marie-Laure Laroche, Antoine Pariente, Jean-Jacques Pere, Odile Regnier, Philippe Truffinet
Publikováno v:
Therapie. 65(4)
As the failure of several recent Phase III drug development programmes bears witness, the clinical development of “disease-modifying” drugs in Alzheimer’s disease has been confronted with challenging methodological difficulties. Taking into acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d59afa840e517b81a8ffd59acd350f1
https://pubmed.ncbi.nlm.nih.gov/20854749
https://pubmed.ncbi.nlm.nih.gov/20854749
Publikováno v:
Therapie. 60(4)
Over the last few years, there has been a rapid and steadily expanding demographic explosion in the elderly population in France. When the most dynamic segment of this growth is considered, i.e. patients aged 80 years or more (who, moreover, usually
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c5eeaedb67b292fa74ae96d5a7fc108
https://pubmed.ncbi.nlm.nih.gov/16268437
https://pubmed.ncbi.nlm.nih.gov/16268437